{"id":10145,"date":"2020-12-02T20:46:46","date_gmt":"2020-12-02T11:46:46","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=10145"},"modified":"2025-08-04T13:55:00","modified_gmt":"2025-08-04T04:55:00","slug":"healthy_disease","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/hps\/patient_specific_ips\/healthy_disease","title":{"rendered":"Healthy relatives of patients"},"content":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address.
\n\uff0a In relation to the information that are not described below, please e-mail to the following address.<\/p>\n

Contact us :\u00a0cellips.brc\"\"riken.jp<\/a><\/p>\n

Blue letter cells are available. You obtain the information by clicking the blue letter.
\n*iPS cells created using the Sendai virus vector are now available<\/a><\/p>\n

*Terms:
\nIn relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary.
\nIn relation to all iPS cell lines, commercial use is prohibited.
\nIn relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize.<\/p>\n

Update : 2020.11.27<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/th>\nPatient No<\/th>\n*Terms<\/th>\nApproval Form<\/th>\nHPS<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\nReferences<\/th>\n<\/tr>\n
1. Miyoshi myopathy<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients (HPS0408\u301cHPS0410)<\/a><\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0411<\/td>\nHPS0412<\/td>\nHPS0413<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. Danon disease<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1806<\/td>\nHPS3665<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Hypertrophic cardiomyopathy (HCM)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients<\/td>\n<\/a>1<\/td>\n<\/td>\n<\/td>\nHPS0955<\/td>\nHPS0956<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4. Myotubular myopathy<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS3868<\/td>\nHPS3869<\/td>\nHPS3870<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5. Branchio-oto-renal syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS3984<\/td>\nHPS3985<\/td>\nHPS3986<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n6. Diamond-Blackfan anemia<\/span><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients (HPS1126\u301cHPS1137)<\/a><\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1138<\/td>\nHPS1139<\/td>\nHPS1140<\/td>\nHPS1141<\/td>\nHPS1142<\/td>\nHPS1143<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS1144<\/td>\nHPS1145<\/td>\nHPS1146<\/td>\nHPS1147<\/td>\nHPS1148<\/td>\nHPS1149<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7. Epstein syndrome<\/a> <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients (HPS0452\u301cHPS0454)<\/a><\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS0455<\/td>\nHPS0456<\/td>\nHPS0457<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8. Rheumatoid Arthritis<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients (HPS1114\u301cHPS1119)<\/a><\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1120<\/td>\nHPS1121<\/td>\nHPS1122<\/td>\nHPS1123<\/td>\nHPS1124<\/td>\nHPS1125<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9. NGLY1 deficiency<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients (HPS3018\u301cHPS3023)<\/a><\/td>\n<\/a>1<\/td>\n<\/td>\nUnnecessary<\/td>\nHPS3024<\/td>\nHPS3025<\/td>\nHPS3026<\/td>\nHPS3027<\/td>\nHPS3028<\/td>\nHPS3029<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n<\/td>\nUnnecessary<\/td>\nHPS3030<\/td>\nHPS3031<\/td>\nHPS3032<\/td>\nHPS3033<\/td>\nHPS3034<\/td>\nHPS3035<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Healthy relatives of patients (HPS3054\u301cHPS3059)<\/a>, (HPS3060\u301cHPS3065)<\/a><\/td>\n1<\/td>\n<\/td>\nUnnecessary<\/td>\nHPS3066<\/td>\nHPS3067<\/td>\nHPS3068<\/td>\nHPS3069<\/td>\nHPS3070<\/td>\nHPS3071<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n<\/td>\nUnnecessary<\/td>\nHPS3072<\/td>\nHPS3073<\/td>\nHPS3074<\/td>\nHPS3075<\/td>\nHPS3076<\/td>\nHPS3077<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\n<\/td>\nUnnecessary<\/td>\nHPS3078<\/td>\nHPS3079<\/td>\nHPS3080<\/td>\nHPS3081<\/td>\nHPS3082<\/td>\nHPS3083<\/td>\n<\/td>\n<\/td>\n<\/tr>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address. \uff0a In relation to the information that are not described below, please e-mail to the following address. Contact us :\u00a0cellips.brcriken.jp Blue letter cells are available. You obtain the information by clicking the blue letter. *iPS cells created using the Sendai virus vector are now available *Terms: In relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary. In relation to all iPS cell lines, commercial use is prohibited. In relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize. Update : 2020.11.27 Patient No *Terms Approval Form HPS References 1. Miyoshi myopathy Healthy relatives of patients (HPS0408\u301cHPS0410) 1 HPS0411 HPS0412 HPS0413 2. Danon disease Healthy relatives of patients 1 HPS1806 HPS3665 3. Hypertrophic cardiomyopathy (HCM) Healthy relatives of patients 1 HPS0955 HPS0956 4. Myotubular myopathy Healthy relatives of patients 1 HPS3868 HPS3869 HPS3870 5. Branchio-oto-renal syndrome Healthy relatives of patients 1 HPS3984 HPS3985 […]<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":10124,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-10145","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=10145"}],"version-history":[{"count":4,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10145\/revisions"}],"predecessor-version":[{"id":10186,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10145\/revisions\/10186"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10124"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=10145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}